Glorioso et al., 2006 - Google Patents
Soluble V Domain of Nectin-1/HveC EnablesGlorioso et al., 2006
View PDF- Document ID
- 5171596701089133295
- Author
- Glorioso J
- Burton E
- Goins W
- Cohen J
- Kwon H
- Bai Q
- Baek H
- Felmet K
- Publication year
- Publication venue
- J. Virol
External Links
Snippet
MATERIALS AND METHODS Cells and viruses. Cricetulus griseus Chinese hamster ovary cells (CHO-K1; ATCC CCL-61) were maintained in Ham's F-12K medium (Gibco-Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS; Gibco). CHO-K1 cells constitutively …
- 102100019072 NECTIN1 0 title abstract description 101
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Campadelli‐Fiume et al. | The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells | |
| Kwon et al. | Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D | |
| JPH10506008A (en) | Protein targeting into HIV virions based on HIV-1 Vpr fusion molecules | |
| US7825085B2 (en) | Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells | |
| Nakano et al. | Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule | |
| Reuter et al. | Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B (gB) is inhibited by antibodies directed at antigenic domain 5 in the ectodomain of gB | |
| WO2022094287A1 (en) | Multivalent particles compositions and methods of use | |
| Kolb et al. | Identification and functional characterization of a novel Fc gamma-binding glycoprotein in rhesus cytomegalovirus | |
| WO1999063063A1 (en) | Cellular proteins which mediate herpesvirus entry | |
| EP4165071A1 (en) | Humanized ace2-fc fusion protein for treatment and prevention of sars-cov-2 infection | |
| Britt et al. | Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B | |
| Kaleeba et al. | Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry | |
| WO2009095500A1 (en) | Inhibitors of lentiviral replication | |
| US7553926B2 (en) | Compositions containing anti-HIV peptides and methods for use | |
| EP1002864A1 (en) | HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections | |
| JP2002538814A (en) | Novel chimeric proteins for prevention and treatment of HIV infection | |
| Li et al. | Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability | |
| Glorioso et al. | Soluble V Domain of Nectin-1/HveC Enables | |
| EP1545602B1 (en) | Pharmaceutical compositions comprising an hiv envelope protein and cd4 | |
| Fuchs et al. | An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension | |
| Tsvitov et al. | Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection | |
| WO1999020761A2 (en) | Compositions and methods for identifying and testing therapeutics against hsv infection | |
| Ficinska et al. | Pseudorabies virus glycoprotein gD contains a functional endocytosis motif that acts in concert with an endocytosis motif in gB to drive internalization of antibody-antigen complexes from the surface of infected monocytes | |
| Subramanian et al. | The nectin-1α transmembrane domain, but not the cytoplasmic tail, influences cell fusion induced by HSV-1 glycoproteins | |
| US6569616B1 (en) | Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate |